Interstitial lung disease associated with gemcitabine treatment in patients with non-small-cell lung cancer and pancreatic cancer

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 10, 2011, Pages 1469-1475

  Umemura, Shigeki ^a   Yamane, Hiromichi ^a   Suwaki, Toshimitsu ^a   Katoh, Tsutomu ^a   Yano, Takuya ^a   Shiote, Yasuhiro ^a   Takigawa, Nagio ^b   Kiura, Katsuyuki ^b   Kamei, Haruhito ^a  

^a Sumitomo Besshi Hospital   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Chemotherapy; Gemcitabine; Interstitial lung disease; Lung cancer; Non small cell; Pancreatic cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; GEMCITABINE; NAVELBINE;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE CALCULATION; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEUTROPENIA; PANCREAS CANCER; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PANCREATIC NEOPLASMS; RISK FACTORS;

EID: 80054726656     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1013-1     Document Type: Article

References (22)

1. O Arrieta D Gallardo-Rincón C Villarreal-Garza RM Michel AM Astorga-Ramos L Martínez-Barrera J de la Garza 2009 High frequency of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin J Thorac Oncol 4 845 852 19487963 10.1097/JTO.0b013e3181a97e17
2. SM Belknap TM Kuzel PR Yarnold N Slimack EA Lyons DW Raisch CL Bennett 2006 Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project Cancer 106 2051 2057 16568459 10.1002/cncr.21808 1:CAS:528:DC%2BD28XkvFGhs7c%3D (Pubitemid 43673222)
3. AW Blackstock C Ho J Butler J Fletcher-Steede LD Case W Hinson AA Miller 2006 Phase Ia/Ib chemo-radiation trial of gemcitabine and dose-escalated thoracic radiation in patients with stage III A/B non-small cell lung cancer J Thorac Oncol 1 434 440 17409896 10.1097/01243894-200606000-00010 (Pubitemid 47181420)
4. S Boeck A Hausmann R Reibke C Schulz V Heinemann 2007 Severe lung and skin toxicity during treatment with gemcitabine and erlotinib for metastatic pancreatic cancer Anticancer Drugs 18 1109 1111 17704662 10.1097/CAD. 0b013e3281ceabec 1:CAS:528:DC%2BD2sXptFCrtrY%3D (Pubitemid 47294905)
5. E Briasoulis N Pavlidis 2001 Noncardiogenic pulmonary edema: an unusual and serious complication of anticancer therapy Oncologist 6 153 161 11306727 10.1634/theoncologist.6-2-153 1:CAS:528:DC%2BD3MXktVarur0%3D (Pubitemid 32323454)
6. HA Burris III MJ Moore J Andersen MR Green ML Rothenberg MR Modiano MC Cripps RK Portenoy AM Storniolo P Tarassoff R Nelson FA Dorr CD Stephens DD Von Hoff 1997 Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J Clin Oncol 15 2403 2413 9196156 1:CAS:528:DyaK2sXlsFKksLY%3D (Pubitemid 27251144)
7. L Crinò AM Mosconi G Scagliotti G Selvaggi S Novello M Rinaldi M Della Giulia C Gridelli A Rossi C Calandri F De Marinis M Noseda M Tonato 1999 Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: a phase II trial J Clin Oncol 17 2081 2085 10561261 (Pubitemid 29318838)
8. A Czarnecki S Voss 2006 Pulmonary toxicity in patients treated with gemcitabine and a combination of gemcitabine and a taxane: investigation of a signal using postmarketing data Br J Cancer 94 1759 1760 16685265 1:CAS:528:DC%2BD28XltVOmurw%3D (Pubitemid 43924944)
9. E Esteban N Villanueva I Muñiz Y Fernández J Fra M Luque P Jiménez B Llorente M Capelan JM Vieitez E Estrada JM Buesa A Jiménez-Lacave 2008 Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study Invest New Drugs 26 67 74 17805486 10.1007/s10637-007-9073-4 1:CAS:528:DC%2BD1cXlt1aqsA%3D%3D
10. FH Galvão JO Pestana VL Capelozzi 2010 Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma Cancer Chemother Pharmacol 65 607 610 19904536 10.1007/s00280-009-1167-6
11. N Gupta I Ahmed H Steinberg D Patel S Nissel-Horowitz B Mehrotra 2002 Gemcitabine-induced pulmonary toxicity: case report and review of the literature Am J Clin Oncol 25 96 100 11823707 10.1097/00000421-200202000-00021 (Pubitemid 34131039)
12. E Ko S Lee A Goodman 2008 Gemcitabine pulmonary toxicity in ovarian cancer Oncologist 13 807 811 18614588 10.1634/theoncologist.2008-0049 1:CAS:528:DC%2BD1cXhtVCqtbvL
13. S Kudoh H Kato Y Nishiwaki M Fukuoka K Nakata Y Ichinose M Tsuboi S Yokota K Nakagawa M Suga Japan Thoracic Radiology Group H Jiang Y Itoh A Armour C Watkins T Higenbottam F Nyberg 2008 Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study Am J Respir Crit Care Med 177 1348 1357 18337594 10.1164/rccm.200710-1501OC (Pubitemid 351860912)
14. D Lorusso G Ferrandina E Fruscella L Marini V Adamo G Scambia 2005 Gemcitabine in epithelial ovarian cancer treatment: current role and future perspectives Int J Gynecol Cancer 15 1002 1013 16343176 10.1111/j.1525-1438. 2005.00331.x 1:STN:280:DC%2BD2Mnmt1Wrtw%3D%3D (Pubitemid 43110148)
15. Y Ohe Y Ohashi K Kubota T Tamura K Nakagawa S Negoro Y Nishiwaki N Saijo Y Ariyoshi M Fukuoka 2007 Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan Ann Oncol 18 317 323 17079694 10.1093/annonc/mdl377 1:STN:280:DC%2BD2s%2Fotlaqsw%3D%3D (Pubitemid 46323100)
16. N Pavlakis DR Bell MJ Millward JA Levi 1997 Fatal pulmonary toxicity resulting from treatment with gemcitabine Cancer 15 286 291 10.1002/(SICI)1097- 0142(19970715)80:2<286::AID-CNCR17>3.0.CO;2-Q (Pubitemid 27282323)
17. DF Roychowdhury CA Cassidy P Peterson M Arning 2002 A report on serious pulmonary toxicity associated with gemcitabine-based therapy Invest New Drugs 20 311 315 12201493 10.1023/A:1016214032272 1:CAS:528:DC%2BD38XltFans70%3D (Pubitemid 34823759)
18. CE Rübe HP Rodemann C Rübe 2004 The relevance of cytokines in the radiation-induced lung reaction. Experimental basis and clinical significance Strahlenther Onkol 180 541 549 15378184 (in German) (Pubitemid 39248786)
19. CE Rübe F Wilfert D Uthe J König L Liu A Schuck N Willich K Remberger C Rübe 2004 Increased expression of pro-inflammatory cytokines as a cause of lung toxicity after combined treatment with gemcitabine and thoracic irradiation Radiother Oncol 72 231 241 15297141 10.1016/j.radonc.2004.05.004 (Pubitemid 39024598)
20. W Shaib F Lansigan D Cornfeld K Syrigos MW Saif 2008 Gemcitabine-induced pulmonary toxicity during adjuvant therapy in a patient with pancreatic cancer JOP 9 708 714 18981552
21. K Takeda S Negoro T Tamura Y Nishiwaki S Kudoh S Yokota K Matsui H Semba K Nakagawa Y Takada M Ando T Shibata N Saijo 2009 Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104) Ann Oncol 20 835 841 19164456 10.1093/annonc/mdn705 1:STN:280:DC%2BD1MzgvVyntg%3D%3D
22. B Vahid PE Marik 2008 Pulmonary complications of novel antineoplastic agents for solid tumors Chest 133 528 538 18252919 10.1378/chest.07-0851 1:CAS:528:DC%2BD1cXjtFemsb4%3D (Pubitemid 351272414)